Another research team found that MPC1 expression is much lower in the primary tumors than in the normal adjacent benign prostate tissues, and is further down-regulated in metastatic prostate tumors, indicating that MPC1 down-regulation may predict a more aggressive prostate cancer. The gene discussed is MPC1; the disease is prostate cancer.